Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m6A/MYC/CEBPA Signaling.

Cell | 2018

R-2-hydroxyglutarate (R-2HG), produced at high levels by mutant isocitrate dehydrogenase 1/2 (IDH1/2) enzymes, was reported as an oncometabolite. We show here that R-2HG also exerts a broad anti-leukemic activity in vitro and in vivo by inhibiting leukemia cell proliferation/viability and by promoting cell-cycle arrest and apoptosis. Mechanistically, R-2HG inhibits fat mass and obesity-associated protein (FTO) activity, thereby increasing global N6-methyladenosine (m6A) RNA modification in R-2HG-sensitive leukemia cells, which in turn decreases the stability of MYC/CEBPA transcripts, leading to the suppression of relevant pathways. Ectopically expressed mutant IDH1 and S-2HG recapitulate the effects of R-2HG. High levels of FTO sensitize leukemic cells to R-2HG, whereas hyperactivation of MYC signaling confers resistance that can be reversed by the inhibition of MYC signaling. R-2HG also displays anti-tumor activity in glioma. Collectively, while R-2HG accumulated in IDH1/2 mutant cancers contributes to cancer initiation, our work demonstrates anti-tumor effects of 2HG in inhibiting proliferation/survival of FTO-high cancer cells via targeting FTO/m6A/MYC/CEBPA signaling.

Pubmed ID: 29249359 RIS Download

Associated grants

  • Agency: NHGRI NIH HHS, United States
    Id: RM1 HG008935
  • Agency: NCI NIH HHS, United States
    Id: R50 CA211404
  • Agency: NCI NIH HHS, United States
    Id: R01 CA182528
  • Agency: Howard Hughes Medical Institute, United States
  • Agency: NIGMS NIH HHS, United States
    Id: R01 GM071440
  • Agency: NCI NIH HHS, United States
    Id: R01 CA214965
  • Agency: NINDS NIH HHS, United States
    Id: R01 NS089815
  • Agency: NCI NIH HHS, United States
    Id: R01 CA168815
  • Agency: NINDS NIH HHS, United States
    Id: R21 NS100077
  • Agency: NCI NIH HHS, United States
    Id: P30 CA033572
  • Agency: NCI NIH HHS, United States
    Id: R01 CA243386
  • Agency: NCI NIH HHS, United States
    Id: R01 CA178454
  • Agency: NCI NIH HHS, United States
    Id: R01 CA211614

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


GraphPad Prism (tool)

RRID:SCR_002798

Statistical analysis software that combines scientific graphing, comprehensive curve fitting (nonlinear regression), understandable statistics, and data organization. Designed for biological research applications in pharmacology, physiology, and other biological fields for data analysis, hypothesis testing, and modeling.

View all literature mentions

CEBP Alpha antibody (antibody)

RRID:AB_2077890

This polyclonal targets CEBP Alpha

View all literature mentions

β-Actin (8H10D10) Mouse mAb (antibody)

RRID:AB_2242334

This monoclonal targets beta-actin

View all literature mentions

goat anti-mouse IgG-HRP (antibody)

RRID:AB_631738

This polyclonal targets goat anti-mouse IgG-HRP

View all literature mentions

donkey anti-rabbit IgG-HRP (antibody)

RRID:AB_631745

This polyclonal targets Rabbit IgG

View all literature mentions

GAPDH Antibody (0411) (antibody)

RRID:AB_627678

This monoclonal targets GAPDH

View all literature mentions

c-Myc antibody [Y69] (antibody)

RRID:AB_731658

This monoclonal targets c-Myc antibody [Y69]

View all literature mentions

H3K36me3-human (antibody)

RRID:AB_306966

This polyclonal targets H3K36me3

View all literature mentions

H3K9me3-human,H3K9me3-mouse (antibody)

RRID:AB_306848

This polyclonal targets H3K9me3

View all literature mentions

FTO antibody [EPR6895] (antibody)

RRID:AB_10972698

This monoclonal targets FTO antibody [EPR6895]

View all literature mentions

Anti-m6A (antibody)

RRID:AB_2279214

This polyclonal targets m6A

View all literature mentions

5-Hydroxymethylcytosine (5-hmC) antibody (antibody)

RRID:AB_10013602

This polyclonal targets 5-Hydroxymethylcytosine (5-hmC)

View all literature mentions